Alantra strengthens its global healthcare team with senior appointment
Date 29 September 2021
London, 29 September 2021 – Alantra, the independent global mid-market investment banking firm, has strengthened its Healthcare sector team with the appointment of Nick Johnston as a Senior Advisor. Alantra’s Global Healthcare team includes over 30 professionals across Europe and the US and Asia and has completed more than 20 deals over the last year. Nick will be based in London.
Nick’s 25-year career spans both investment banking advisory and industry positions in the UK and US. He has held senior positions in the healthcare investment banking teams at Perella Weinberg and JP Morgan advising companies across multiple sub-sectors with a particular focus in biotechnology, medical technology, diagnostics and digital health. Nick has also served as the chief operating officer of a specialist medical device developer and co-founded a development-stage drug discovery company in respiratory health and other indications. He also serves on the board of a medical device company.
Justin Crowther, Alantra partner and UK head of healthcare, commented, “Nick is a highly respected advisor across the biotechnology, medical technology, diagnostics and digital health sectors and his appointment strengthens our healthcare team in the UK and globally. He reinforces our commitment to ensuring our clients are working with world-class advisors who have in-depth sector expertise and relationships, an excellent transaction track record and industry experience.”
Nick Johnston, Senior Advisor, Alantra Healthcare, said, “Healthcare is one of the most active sectors for M&A and there are often numerous options available to business owners and management teams seeking investment or other strategic solutions. Navigating these options requires a combination of deep sector expertise – especially in a sector as complex and dynamic as healthcare – and broad experience in the many facets of corporate finance. Alantra’s engaged global team of senior healthcare advisors is well positioned to meet these needs as companies research, develop and, if necessary, start commercialising their technology; I am delighted to be joining them.”